Furthermore, serum IGF-1 and hemoglobin levels should be repeatedly measured to confirm the associations between the two to provide a theoretical basis for prospective and interventional studies on the treatment of IGF-1 in patients undergoing MHD with anemia. This evidence concerns the gene IGF1 and anemia (phenotype).